PDZD11
gene geneOn this page
Summary
PDZD11 (PDZ domain containing 11, HGNC:28034) is a protein-coding gene on chromosome Xq13.1, encoding PDZ domain-containing protein 11 (Q5EBL8). Mediates docking of ADAM10 to zonula adherens by interacting with PLEKHA7 which is required for PLEKHA7 to interact with the ADAM10-binding protein TSPAN33.
Predicted to enable protein-macromolecule adaptor activity. Involved in pore complex assembly. Located in basolateral plasma membrane and cytosol. Part of pore complex.
Source: NCBI Gene 51248 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 39 total
- MANE Select transcript:
NM_016484
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28034 |
| Approved symbol | PDZD11 |
| Name | PDZ domain containing 11 |
| Location | Xq13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000120509 |
| Ensembl biotype | protein_coding |
| OMIM | 300632 |
| Entrez | 51248 |
Gene structure
Transcript identifiers
Ensembl transcripts: 30 — 28 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000239666, ENST00000374454, ENST00000473667, ENST00000486461, ENST00000695560, ENST00000695561, ENST00000859554, ENST00000859555, ENST00000859556, ENST00000859557, ENST00000859558, ENST00000859559, ENST00000859560, ENST00000859561, ENST00000859562, ENST00000859563, ENST00000924462, ENST00000924463, ENST00000924464, ENST00000924465, ENST00000924466, ENST00000924467, ENST00000924468, ENST00000924469, ENST00000924470, ENST00000924471, ENST00000967454, ENST00000967455, ENST00000967456, ENST00000967457
RefSeq mRNA: 6 — MANE Select: NM_016484
NM_001370174, NM_001370175, NM_001370176, NM_001370177, NM_001370178, NM_016484
CCDS: CCDS14400
Canonical transcript exons
ENST00000239666 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000672292 | 70287732 | 70287830 |
| ENSE00000672294 | 70287276 | 70287336 |
| ENSE00003527296 | 70289255 | 70289354 |
| ENSE00003529566 | 70288430 | 70288513 |
| ENSE00003550337 | 70288117 | 70288173 |
| ENSE00003964286 | 70286595 | 70287116 |
| ENSE00003964289 | 70289860 | 70289927 |
Expression profiles
Bgee: expression breadth ubiquitous, 261 present calls, max score 97.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 52.0938 / max 465.3557, expressed in 1817 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199529 | 52.0938 | 1817 |
Top tissues by expression
263 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 97.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.10 | gold quality |
| parotid gland | UBERON:0001831 | 95.91 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 95.89 | gold quality |
| hypothalamus | UBERON:0001898 | 95.74 | gold quality |
| prefrontal cortex | UBERON:0000451 | 95.59 | gold quality |
| myocardium | UBERON:0002349 | 95.59 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.48 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 95.43 | gold quality |
| substantia nigra | UBERON:0002038 | 95.38 | gold quality |
| amygdala | UBERON:0001876 | 95.29 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.25 | gold quality |
| embryo | UBERON:0000922 | 95.08 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.08 | gold quality |
| midbrain | UBERON:0001891 | 95.02 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 94.94 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 94.85 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 94.67 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.57 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.50 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.49 | gold quality |
| retina | UBERON:0000966 | 94.47 | gold quality |
| rectum | UBERON:0001052 | 94.46 | gold quality |
| caudate nucleus | UBERON:0001873 | 94.46 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 94.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.37 | gold quality |
| putamen | UBERON:0001874 | 94.36 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.35 | gold quality |
| pancreatic ductal cell | CL:0002079 | 94.34 | silver quality |
| frontal cortex | UBERON:0001870 | 94.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
73 targeting PDZD11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
Literature-anchored findings (GeneRIF, showing 4)
- PDZD11 is an interacting partner with sodium-dependent multivitamin transporter in intestinal epithelial cells and that this interaction affects SMVT function and cell biology. (PMID:21183659)
- PDZD11 forms a complex with nectin-1 and nectin-3, and its PDZ domain interacts directly with the PDZ-binding motif of nectin-1. (PMID:27044745)
- Cooperative binding of the tandem WW domains of PLEKHA7 to PDZD11 promotes conformation-dependent interaction with tetraspanin 33. (PMID:32371390)
- The PLEKHA7-PDZD11 complex regulates the localization of the calcium pump PMCA and calcium handling in cultured cells. (PMID:35714771)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pdzd11 | ENSDARG00000053194 |
| mus_musculus | Pdzd11 | ENSMUSG00000015668 |
| rattus_norvegicus | Pdzd11 | ENSRNOG00000084220 |
| drosophila_melanogaster | veli | FBGN0039269 |
| caenorhabditis_elegans | WBGENE00002996 |
Paralogs (3): LIN7B (ENSG00000104863), LIN7A (ENSG00000111052), LIN7C (ENSG00000148943)
Protein
Protein identifiers
PDZ domain-containing protein 11 — Q5EBL8 (reviewed: Q5EBL8)
Alternative names: ATPase-interacting PDZ protein, Plasma membrane calcium ATPase-interacting single-PDZ protein
All UniProt accessions (1): Q5EBL8
UniProt curated annotations — full annotation on UniProt →
Function. Mediates docking of ADAM10 to zonula adherens by interacting with PLEKHA7 which is required for PLEKHA7 to interact with the ADAM10-binding protein TSPAN33.
Subunit / interactions. Interacts with ATP2B1, ATP2B2, ATP2B3, ATP2B4 and ATP7A. Interacts with PLEKHA7 (via WW domains) at zonula adherens; this interaction is essential for the interaction between PLEKHA7 and the ADAM10-binding protein TSPAN33. Interacts with SLC5A6.
Subcellular location. Secreted Cytoplasm. Cell junction. Adherens junction. Cell membrane.
Tissue specificity. Widely expressed (at protein level).
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5EBL8-1 | 1, AIPP1a | yes |
| Q5EBL8-2 | 2, AIPP1b |
RefSeq proteins (6): NP_001357103, NP_001357104, NP_001357105, NP_001357106, NP_001357107, NP_057568* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001478 | PDZ | Domain |
| IPR036034 | PDZ_sf | Homologous_superfamily |
| IPR051109 | MAM_complex_regulator | Family |
Pfam: PF00595
UniProt features (4 total): chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5EBL8-F1 | 81.99 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-196780 | Biotin transport and metabolism |
| R-HSA-199220 | Vitamin B5 (pantothenate) metabolism |
| R-HSA-425397 | Transport of vitamins, nucleosides, and related molecules |
| R-HSA-6803544 | Ion influx/efflux at host-pathogen interface |
| R-HSA-936837 | Ion transport by P-type ATPases |
MSigDB gene sets: 164 (showing top):
GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT, GOBP_SYNAPTIC_VESICLE_LOCALIZATION, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_VESICLE_LOCALIZATION, GOBP_SYNAPSE_ASSEMBLY, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_GROWTH, GOBP_NEUROTRANSMITTER_TRANSPORT, GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, CAGCTG_AP4_Q5, GOBP_CELL_CELL_SIGNALING, GOBP_CELL_JUNCTION_ORGANIZATION, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY
GO Biological Process (4): neurotransmitter secretion (GO:0007269), regulation of synaptic assembly at neuromuscular junction (GO:0008582), pore complex assembly (GO:0046931), synaptic vesicle transport (GO:0048489)
GO Molecular Function (2): protein-macromolecule adaptor activity (GO:0030674), protein binding (GO:0005515)
GO Cellular Component (11): extracellular region (GO:0005576), cytosol (GO:0005829), cell-cell junction (GO:0005911), adherens junction (GO:0005912), basolateral plasma membrane (GO:0016323), pore complex (GO:0046930), presynapse (GO:0098793), cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), anchoring junction (GO:0070161)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Metabolism of water-soluble vitamins and cofactors | 2 |
| SLC-mediated transmembrane transport | 1 |
| Antimicrobial peptides | 1 |
| Ion channel transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| neurotransmitter transport | 1 |
| chemical synaptic transmission | 1 |
| establishment of localization in cell | 1 |
| presynapse | 1 |
| signal release from synapse | 1 |
| regulation of developmental growth | 1 |
| synaptic assembly at neuromuscular junction | 1 |
| regulation of synapse assembly | 1 |
| regulation of neuromuscular junction development | 1 |
| protein-containing complex assembly | 1 |
| transport | 1 |
| cellular process | 1 |
| establishment of vesicle localization | 1 |
| synaptic vesicle localization | 1 |
| protein binding | 1 |
| molecular adaptor activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| anchoring junction | 1 |
| cell-cell junction | 1 |
| basal plasma membrane | 1 |
| plasma membrane region | 1 |
| membrane protein complex | 1 |
| synapse | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
948 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PDZD11 | KIF4A | O95239 | 806 |
| PDZD11 | ATP7A | Q04656 | 776 |
| PDZD11 | PLEKHA7 | Q6IQ23 | 767 |
| PDZD11 | TSPAN33 | Q86UF1 | 665 |
| PDZD11 | AFDN | P55196 | 625 |
| PDZD11 | SLC5A6 | Q9Y289 | 609 |
| PDZD11 | CGNL1 | Q0VF96 | 495 |
| PDZD11 | NECTIN3 | Q9NQS3 | 482 |
| PDZD11 | PLEKHA5 | Q9HAU0 | 467 |
| PDZD11 | MISP | Q8IVT2 | 446 |
| PDZD11 | SMCO4 | Q9NRQ5 | 436 |
| PDZD11 | MED31 | Q9Y3C7 | 435 |
| PDZD11 | ITM2C | Q9NQX7 | 431 |
| PDZD11 | SNTA1 | Q13424 | 400 |
| PDZD11 | WWC3 | Q9ULE0 | 394 |
IntAct
103 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YWHAH | ABLIM1 | psi-mi:“MI:0914”(association) | 0.800 |
| PLEKHA5 | PDZD11 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PDZD11 | PLEKHA5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PDZD11 | ATP7A | psi-mi:“MI:0915”(physical association) | 0.610 |
| ATP7A | PDZD11 | psi-mi:“MI:0915”(physical association) | 0.610 |
| PDZD11 | SLC5A6 | psi-mi:“MI:0915”(physical association) | 0.600 |
| SLC5A6 | PDZD11 | psi-mi:“MI:0915”(physical association) | 0.600 |
| PDZD11 | SLC5A6 | psi-mi:“MI:0403”(colocalization) | 0.600 |
| SUMO1 | CBX4 | psi-mi:“MI:0914”(association) | 0.600 |
| PDZD11 | MAGI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| rep | SBNO1 | psi-mi:“MI:0914”(association) | 0.530 |
| YWHAZ | BLTP3B | psi-mi:“MI:0914”(association) | 0.530 |
| TGM5 | UBB | psi-mi:“MI:0914”(association) | 0.530 |
| GINM1 | ADCY9 | psi-mi:“MI:0914”(association) | 0.530 |
| Tax | TAX1BP3 | psi-mi:“MI:0914”(association) | 0.520 |
| PDZD11 | psi-mi:“MI:0915”(physical association) | 0.490 | |
| PDZD11 | psi-mi:“MI:0915”(physical association) | 0.490 | |
| ABCC4 | PDZD11 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| KIR3DL3 | PDZD11 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (84): PLEKHA5 (Two-hybrid), PDZD11 (Affinity Capture-MS), PDZD11 (Affinity Capture-MS), PDZD11 (Proximity Label-MS), PDZD11 (Proximity Label-MS), PDZD11 (Proximity Label-MS), PDZD11 (Proximity Label-MS), PDZD11 (Proximity Label-MS), PDZD11 (Affinity Capture-MS), PDZD11 (Affinity Capture-MS), PDZD11 (Affinity Capture-MS), PDZD11 (Affinity Capture-MS), CBY1 (Affinity Capture-MS), PDZD11 (Affinity Capture-MS), PDZD11 (Affinity Capture-MS)
ESM2 similar proteins: A5PKA5, A6QLK6, O14508, O54865, O75382, P09851, P16068, P20595, P20936, P49138, P50904, P57790, P62993, P62994, Q02153, Q07883, Q13588, Q14145, Q3UHD6, Q3ZCI3, Q4R539, Q4ZHR9, Q5EBL8, Q5PR73, Q5R4J7, Q5R4Q7, Q5R6S2, Q5R774, Q5RKN4, Q5ZLD3, Q5ZLT5, Q60631, Q684M4, Q7YRV6, Q861R0, Q8K4V4, Q8N653, Q8TC17, Q95KD9, Q96HU8
Diamond homologs: A0A0G2K2P5, A0A8P0N4K0, C5IAW9, F1LW30, O08721, O08722, O08747, O62683, O95049, O95185, O97758, P39447, P57105, Q07157, Q0P5E6, Q13424, Q28626, Q32LE7, Q3T0C9, Q5EBL8, Q5ZIK2, Q61234, Q6NXB2, Q6QA76, Q6R653, Q6UXZ4, Q6ZN44, Q761X5, Q7KRY7, Q7T2Z5, Q80VW5, Q86UL8, Q8IV45, Q8IZJ1, Q8JGT4, Q8K1S2, Q8K1S3, Q8K1S4, Q95168, Q9CZG9
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PDZD11 | “up-regulates activity” | TSPAN33 | binding |
| PLEKHA7 | “up-regulates activity” | PDZD11 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 105 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Activation of BAD and translocation to mitochondria | 5 | 53.6× | 6e-06 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 5 | 47.3× | 6e-06 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 5 | 47.3× | 6e-06 |
| Activation of BH3-only proteins | 5 | 35.0× | 3e-05 |
| RHO GTPases activate PKNs | 5 | 22.3× | 2e-04 |
| Intrinsic Pathway for Apoptosis | 5 | 20.6× | 3e-04 |
| G2/M Checkpoints | 8 | 15.1× | 6e-06 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 6 | 13.0× | 5e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
39 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 7 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2211 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:70282290:GAA:G | donor_gain | 1.0000 |
| X:70282329:G:GT | donor_gain | 1.0000 |
| X:70282331:A:T | donor_gain | 1.0000 |
| X:70282856:G:GG | donor_gain | 1.0000 |
| X:70283374:G:GG | donor_gain | 1.0000 |
| X:70283626:T:A | donor_loss | 1.0000 |
| X:70283938:T:A | acceptor_gain | 1.0000 |
| X:70283943:C:CA | acceptor_gain | 1.0000 |
| X:70283945:TCCA:T | acceptor_loss | 1.0000 |
| X:70283946:CCA:C | acceptor_loss | 1.0000 |
| X:70283948:A:AC | acceptor_loss | 1.0000 |
| X:70283948:A:AG | acceptor_gain | 1.0000 |
| X:70283949:G:GA | acceptor_gain | 1.0000 |
| X:70283949:GA:G | acceptor_gain | 1.0000 |
| X:70283949:GAC:G | acceptor_gain | 1.0000 |
| X:70283949:GACA:G | acceptor_gain | 1.0000 |
| X:70283949:GACAA:G | acceptor_gain | 1.0000 |
| X:70284040:AAAGG:A | donor_loss | 1.0000 |
| X:70284042:AGG:A | donor_loss | 1.0000 |
| X:70284044:G:GA | donor_loss | 1.0000 |
| X:70284045:T:A | donor_loss | 1.0000 |
| X:70284240:T:A | acceptor_gain | 1.0000 |
| X:70287274:A:AC | donor_gain | 1.0000 |
| X:70287275:C:CT | donor_gain | 1.0000 |
| X:70287333:CAGC:C | acceptor_gain | 1.0000 |
| X:70287727:CTCA:C | donor_loss | 1.0000 |
| X:70287728:TCA:T | donor_loss | 1.0000 |
| X:70287729:CAC:C | donor_loss | 1.0000 |
| X:70287731:CCTTG:C | donor_gain | 1.0000 |
| X:70287827:TCAC:T | acceptor_gain | 1.0000 |
AlphaMissense
922 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:70288169:C:T | G59E | 1.000 |
| X:70287323:A:G | L114P | 0.999 |
| X:70287781:T:G | Q93P | 0.999 |
| X:70287784:T:C | D92G | 0.999 |
| X:70287796:A:G | L88P | 0.999 |
| X:70287818:A:G | S81P | 0.999 |
| X:70288124:A:T | I74N | 0.999 |
| X:70288126:G:C | F73L | 0.999 |
| X:70288126:G:T | F73L | 0.999 |
| X:70288128:A:G | F73L | 0.999 |
| X:70288160:A:C | I62S | 0.999 |
| X:70288160:A:G | I62T | 0.999 |
| X:70288160:A:T | I62N | 0.999 |
| X:70288166:A:G | F60S | 0.999 |
| X:70288170:C:G | G59R | 0.999 |
| X:70288170:C:T | G59R | 0.999 |
| X:70287290:C:G | R125P | 0.998 |
| X:70287323:A:T | L114Q | 0.998 |
| X:70287335:G:T | A110D | 0.998 |
| X:70287778:A:T | V94D | 0.998 |
| X:70287784:T:A | D92V | 0.998 |
| X:70287784:T:G | D92A | 0.998 |
| X:70287796:A:T | L88Q | 0.998 |
| X:70287811:G:T | A83E | 0.998 |
| X:70288122:A:G | S75P | 0.998 |
| X:70288124:A:C | I74S | 0.998 |
| X:70288154:C:T | G64E | 0.998 |
| X:70288155:C:G | G64R | 0.998 |
| X:70288155:C:T | G64R | 0.998 |
| X:70288165:A:C | F60L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1002108254 (X:70289897 T>C), RS1003676719 (X:70288970 C>A), RS1004016687 (X:70291480 G>C), RS1004070386 (X:70291103 C>T), RS1004243191 (X:70287573 TCCTC>T), RS1007415639 (X:70286176 G>A), RS1007586723 (X:70287876 A>G), RS1007636919 (X:70288510 C>A,G), RS1008367388 (X:70288984 A>G), RS1008419626 (X:70288704 C>A), RS1010760416 (X:70289751 G>A,C), RS1011023298 (X:70286567 T>C), RS1012541889 (X:70286457 G>C), RS1017157081 (X:70288004 C>A,T), RS1017310097 (X:70291441 G>A)
Disease associations
OMIM: gene MIM:300632 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation, decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.